Report of possible $5 billion takeover bid sends Option Care Health stock surging

A deal would value the infusion provider at more than $5 billion.

Can Digital Data Be Created Where 'Copying Makes a Difference' — Thinking About Distinguishing Originals from Copies

When you dub a cassette tape, the sound becomes slightly muffled. The more you dub, the more the noise increases. In the analog era, copying was not only time-consuming, but it also naturally left ...
Yahoo Finance

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Wall Street Journal

CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

CD&R and McKesson MCK-1.14%decrease; down pointing triangle will acquire Option Care Health, which offers infusion therapy and services to patients at home, for about $5.8 billion including debt.
The Financial Times

McKesson and CD&R strike $5.8bn deal to buy infusion services provider

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Healthcare group McKesson and private equity firm Clayton Dubilier & Rice are teaming up to buy the largest ...
Reuters

McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports

Oct 5 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider ‌Option Care Health in a ...